company

NEVROSENTERET AS

0377 OSLO

Return on Equity
−4,58 %
Current Ratio
2 146,67
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue66 000
Net Income−295 000
Total Assets6 440 000
Total Equity6 437 000
Income (NOK)2022
Revenue66 000
Expenditure48 000
Operating Profit18 000
Financial Income97 000
Financial Costs408 000
Financial Balance−311 000
Earnings Before Tax−293 000
Tax3 000
Net Income−295 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets6 440 000
Total Assets6 440 000
Total Retained Equity6 312 000
Total Equity6 437 000
Total Long-Term Debt0
Total Current Debt3 000
Total Equity and Debt6 440 000
Cash flow (NOK)2022
Sales Income66 000
Other Income0
Revenue66 000
Cost of Goods Sold5 000
Salary Costs5 000
Depreciation0
Impairment0
Expenditure48 000
Operating Profit18 000
Financial Income97 000
Financial Costs408 000
Financial Balance−311 000
Dividends0
Net Income−295 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments5 497 000
Cash, Bank923 000
Total Current Assets6 440 000
Total Assets6 440 000
Total Equity6 437 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt0
Total Current Debt3 000
Total Equity and Debt6 440 000
Financial indicators2022
Return on Equity−4,58 %
Debt-to-Equity Ratio0
Operating Profit Margin27,27 %
Current Ratio2 146,67
Quick Ratio2 146,67
Equity Ratio1
Gross Profit Margin92,42 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English